Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ABCIXIMAB for Percutaneous coronary intervention: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 49 adverse event reports in the FDA FAERS database where ABCIXIMAB was used for Percutaneous coronary intervention.

Most Reported Side Effects for ABCIXIMAB

Side Effect Reports % Deaths Hosp.
Thrombocytopenia 71 22.1% 2 34
Off label use 35 10.9% 3 4
Haemorrhage 29 9.0% 6 7
Incorrect route of drug administration 28 8.7% 0 1
Haemorrhage intracranial 23 7.1% 8 5
Anaemia 22 6.8% 2 17
Drug interaction 17 5.3% 7 7
Product use issue 17 5.3% 1 1
Vascular stent thrombosis 17 5.3% 2 5
Cerebral haemorrhage 15 4.7% 4 3
Petechiae 15 4.7% 0 13
Haemorrhagic transformation stroke 14 4.4% 12 3
Labelled drug-drug interaction medication error 14 4.4% 0 11
Pulmonary haemorrhage 14 4.4% 13 1
Hypotension 13 4.0% 2 10

Other Indications for ABCIXIMAB

Product used for unknown indication (71) Acute myocardial infarction (30) Ischaemic stroke (19) Acute coronary syndrome (18) Thrombosis (17) Antiplatelet therapy (13) Stent placement (12) Myocardial infarction (11) Catheter placement (8) Angiocardiogram (7)

Other Drugs Used for Percutaneous coronary intervention

PRASUGREL (376) CLOPIDOGREL BISULFATE (356) TICAGRELOR (297) ASPIRIN (227) BIVALIRUDIN (159) CANGRELOR (94) HEPARIN (86) INVESTIGATIONAL PRODUCT (46) IODIXANOL (29) IOHEXOL (21)

Related Pages

ABCIXIMAB Full Profile All Percutaneous coronary intervention Drugs ABCIXIMAB Demographics ABCIXIMAB Timeline